EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes blaKPC, blaOXA48, blaVIM and blaNDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead

Martin Reinicke, Celia Diezel, Salma Teimoori, Bernd Haase, Stefan Monecke iD, Ralf Ehricht iD, Sascha D Braun

International Journal of Molecular Sciences · 30.01.2025 · 26 (3) · 1218

DOI: 10.3390/ijms26031218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.01.2025. Verfasst von Martin Reinicke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Photonic Technology, Leibniz Centre for Photonics in Infection Research (LPI), 07745 Jena, Germany. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Real-Time Polymerase Chain Reaction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance, in particular the dissemination of carbapenemase-producing organisms, poses a significant threat to global healthcare. This study introduces the qPCR CarbaScan LyoBead assay, a robust, accurate, and efficient tool for detecting key carbapenemase genes, including blaKPC, blaNDM, blaOXA-48, and blaVIM. The assay utilizes lyophilized beads, a technological advancement that enhances stability, simplifies handling, and eliminates the need for refrigeration. This feature renders it particularly well-suited for point-of-care diagnostics and resource-limited settings. The assay’s capacity to detect carbapenemase genes directly from bacterial colonies without the need for extensive sample preparation has been demonstrated to streamline workflows and enable rapid diagnostic results. The assay demonstrated 100% specificity and sensitivity across a diverse range of bacterial strains, including multiple allelic variants of target genes, facilitating precise identification of resistance mechanisms. Bacterial strains of the species Acinetobacter baumannii, Citrobacter freundii, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae and Pseudomonas aeruginosa were utilized as reference material for assay development (n = 9) and validation (n = 28). It is notable that the assay’s long shelf life and minimal operational complexity further enhance its utility for large-scale implementation in healthcare, food safety, and environmental monitoring. The findings emphasize the necessity of continuous surveillance and the implementation of rapid diagnostic methods for the effective detection of resistance genes. Furthermore, the assay’s potential applications in other fields, such as toxin-antitoxin system research and monitoring of resistant bacteria in the community, highlight its versatility. In conclusion, the qPCR CarbaScan LyoBead assay is a valuable tool that can contribute to the urgent need to combat antibiotic resistance and improve global public health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsReal-Time Polymerase Chain ReactionMicrobial Sensitivity TestsHumansDrug Resistance, BacterialSensitivity and Specificity

Stichwörter der Autor:innen

LyoBead multiplex assaycarbapenemase detectioncarbapenemase resistancemulti-drug resistant gram-negative bacteriapoint-of-care diagnosticsready-to-use

Substanzen

beta-LactamasesBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • Leibniz Institute of Photonic Technology, Leibniz Centre for Photonics in Infection Research (LPI), 07745 Jena, Germany.
  • InfectoGnostics Research Campus, 07743 Jena, Germany.
  • biotechrabbit GmbH, 12489 Berlin, Germany.
  • Institute of Physical Chemistry, Friedrich-Schiller University, 07743 Jena, Germany.

ORCID-Profile: Stefan Monecke, Ralf Ehricht

Förderung

  • Federal Ministry of Education and Research

Zitieren

APA

Reinicke, M., Diezel, C., Teimoori, S., Haase, B., Monecke, S., Ehricht, R., & Braun, S. D. (2025). Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes blaKPC, blaOXA48, blaVIM and blaNDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead. International Journal of Molecular Sciences, 26(3), 1218. https://doi.org/10.3390/ijms26031218

Vancouver

Reinicke M, Diezel C, Teimoori S, Haase B, Monecke S, Ehricht R, et al. Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes blaKPC, blaOXA48, blaVIM and blaNDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead. International Journal of Molecular Sciences. 2025;26(3):1218. doi:10.3390/ijms26031218

BibTeX
@article{Reinicke2025,
  author = {Reinicke, Martin and Diezel, Celia and Teimoori, Salma and Haase, Bernd and Monecke, Stefan and Ehricht, Ralf and Braun, Sascha D},
  title = {Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes blaKPC, blaOXA48, blaVIM and blaNDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {1218},
  doi = {10.3390/ijms26031218}
}
Kostenlos starten →